Skip to content

Source filing unavailable

Q1 2020 · —
Revenue—
Net Income-$3.83Mno prior Q1 2019 on file
EPS Diluted-$4.58no prior Q1 2019 on file
Operating Income-$3,894,000—
Operating Cash Flow-$3,399,000—
Free Cash Flowderived-$3,848,000—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q1 2019 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Werewolf Therapeutics, Inc. · CIK 1785530 · Engraved from SEC EDGAR